| Rodent models for human polycystic ovary syndrome KA Walters, CM Allan, DJ Handelsman Biology of reproduction 86 (5), 149, 1-12, 2012 | 383 | 2012 |
| Androgen actions and the ovary KA Walters, CM Allan, DJ Handelsman Biology of reproduction 78 (3), 380-389, 2008 | 307 | 2008 |
| Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models ASL Caldwell, LJ Middleton, M Jimenez, R Desai, AC McMahon, ... Endocrinology 155 (8), 3146-3159, 2014 | 304 | 2014 |
| Animal models to understand the etiology and pathophysiology of polycystic ovary syndrome E Stener-Victorin, V Padmanabhan, KA Walters, RE Campbell, A Benrick, ... Endocrine reviews 41 (4), bnaa010, 2020 | 231 | 2020 |
| NAD+ repletion rescues female fertility during reproductive aging MJ Bertoldo, DR Listijono, WHJ Ho, AH Riepsamen, DM Goss, D Richani, ... Cell reports 30 (6), 1670-1681. e7, 2020 | 225 | 2020 |
| Macronutrient balance, reproductive function, and lifespan in aging mice SM Solon-Biet, KA Walters, UK Simanainen, AC McMahon, K Ruohonen, ... Proceedings of the National Academy of Sciences 112 (11), 3481-3486, 2015 | 219 | 2015 |
| Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome ASL Caldwell, MC Edwards, R Desai, M Jimenez, RB Gilchrist, ... Proceedings of the National Academy of Sciences 114 (16), E3334-E3343, 2017 | 208 | 2017 |
| Defining the nutritional and metabolic context of FGF21 using the geometric framework SM Solon-Biet, VC Cogger, T Pulpitel, M Heblinski, D Wahl, AC McMahon, ... Cell metabolism 24 (4), 555-565, 2016 | 204 | 2016 |
| Molecular insights into androgen actions in male and female reproductive function from androgen receptor knockout models KA Walters, U Simanainen, DJ Handelsman Human reproduction update 16 (5), 543-558, 2010 | 203 | 2010 |
| Female mice haploinsufficient for an inactivated androgen receptor (AR) exhibit age-dependent defects that resemble the AR null phenotype of dysfunctional late follicle … KA Walters, CM Allan, M Jimenez, PR Lim, RA Davey, JD Zajac, ... Endocrinology 148 (8), 3674-3684, 2007 | 172 | 2007 |
| Role of androgens in normal and pathological ovarian function KA Walters Reproduction 149 (4), R193-R218, 2015 | 171 | 2015 |
| The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review RJ Rodgers, GD Reid, J Koch, R Deans, WL Ledger, M Friedlander, ... Human Reproduction 32 (5), 1033-1045, 2017 | 145 | 2017 |
| Measurement of sex steroids in murine blood and reproductive tissues by liquid chromatography–tandem mass spectrometry KM McNamara, DT Harwood, U Simanainen, KA Walters, M Jimenez, ... The Journal of steroid biochemistry and molecular biology 121 (3-5), 611-618, 2010 | 139 | 2010 |
| New perspectives on the pathogenesis of PCOS: neuroendocrine origins KA Walters, RB Gilchrist, WL Ledger, HJ Teede, DJ Handelsman, ... Trends in Endocrinology & Metabolism 29 (12), 841-852, 2018 | 138 | 2018 |
| Targeted loss of androgen receptor signaling in murine granulosa cells of preantral and antral follicles causes female subfertility KA Walters, LJ Middleton, SR Joseph, R Hazra, M Jimenez, ... Biology of reproduction 87 (6), 151, 1-11, 2012 | 134 | 2012 |
| Subfertile female androgen receptor knockout mice exhibit defects in neuroendocrine signaling, intraovarian function, and uterine development but not uterine function KA Walters, KJ McTavish, MG Seneviratne, M Jimenez, AC McMahon, ... Endocrinology 150 (7), 3274-3282, 2009 | 112 | 2009 |
| Rising follicle-stimulating hormone levels with age accelerate female reproductive failure KJ McTavish, M Jimenez, KA Walters, J Spaliviero, NP Groome, ... Endocrinology 148 (9), 4432-4439, 2007 | 97 | 2007 |
| Role of androgens in the ovary KA Walters, DJ Handelsman Molecular and cellular endocrinology 465, 36-47, 2018 | 95 | 2018 |
| Evidence from animal models on the pathogenesis of PCOS KA Walters, MJ Bertoldo, DJ Handelsman Best Practice & Research Clinical Endocrinology & Metabolism 32 (3), 271-281, 2018 | 93 | 2018 |
| Haplosufficient genomic androgen receptor signaling is adequate to protect female mice from induction of polycystic ovary syndrome features by prenatal hyperandrogenization ASL Caldwell, S Eid, CR Kay, M Jimenez, AC McMahon, R Desai, ... Endocrinology 156 (4), 1441-1452, 2015 | 90 | 2015 |
